Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 20 Biotech Angel Investors in Switzerland

Last updated: Apr 2024 A list of 20 angel investors that invest in Biotech startups based in Switzerland. We rank investors based on the number of investments they made in Biotech companies from Switzerland. We update this investor list every month.

Top 20 Biotech Angel Investors in Switzerland

Investor	Biotech Switzerland investments
Penny Schiffer	4
John Zimmer	1
Walter Fischl	1
Ulf Claesson	1
Nicolas Mermod	1
Patrick Delarive	1
Reinhard Ambros	1
Thorsten Schroeder	1
Arda Kara	1
Alexsis de Raadt-St. James	1
Chris Gibson	1
Thomas Glocer	1
Tobias Reichmuth	1
Lukas Speiser	1
Feike Sijbesma	1
Emily Leproust	1
Igor Fish	1
Lucian Wagner	1
Tej Tadi	1
Beat Schillig	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Penny Schiffer - CEO & Co-founder @ Raized.ai

Investment focus

Health Care, Medical, Finance
Funding Round, Seed, Series A
Switzerland, Germany, United Kingdom

Portfolio highlights

Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.

John Zimmer is the co-founder and President of Lyft, the on-demand ridesharing platform, that was founded in 2007 with Zimride as its first of two products built to create a more social, sustainable and affordable transportation system. John’s interest in peer-to-peer transportation began at Cornell’s School of Hotel Administration. Uponlearning that only 20% of seats in cars on highways are occupied, he began working on ways to use existing information infrastructures to solve the problem of unused empty seats. After graduating first in his class, John spent two years at Lehman Brothers before (luckily) leaving to rideshare his way from New York to San Francisco to join co-founder Logan Green in launching Zimride. John was recognized in 2009 as one of Businessweek's Top 25 Entrepreneurs Under 25, and has spoken at top tier events such as SXSW, The Association for Commuter Transportation (ACT) International Conference and Stanford Business School. With Lyft, John hopes to fix the current state of transportation across the country, and eventually around the world, to make cities safer, more affordable and better connected. Since unveiling the product in June 2012, Lyft has quickly become one of the fastest-growing tech companies with more than $80 million raised from leading investors Andreessen Horowitz and Founders Fund and has been featured in The Economist, the New York Times and on NBC’s TODAY Show. Lyft is currently available in San Francisco, Los Angeles, Seattle, San Diego, Chicago, Boston and Washington, D.C., with more than a million rides shared on the platform to date.

Investment focus

Mining, FinTech, Mineral
Series B, Seed
United States, Switzerland

Portfolio highlights

Deel — With Deel, your business can easily hire anywhere. No more worrying about local laws, complex tax systems, or managing international payroll. Deel takes care of everything in 150+ countries.
Cradle — Design better proteins
KoBold Metals — KoBold Metals is investing in battery materials projects across the globe by combining basic ore-deposit science, big data, and scientific computing with patient private capital.The company's software uses datasets with conventional geochemical, geophysical and geological data in statistical association models to identify prospects to ensure acobalt supply for the electric vehicle revolution, enabling mineral exploration companies to find new sources of cobalt through machine learning and data analysis.

Walter Fischl

Investment focus

Medical, Health Care, Biotechnology
Funding Round
Switzerland

Portfolio highlights

ProteoMediX — ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinicalstandard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

Ulf Claesson

Investment focus

Biotechnology, Food and Beverage
Seed
Switzerland

Portfolio highlights

MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment

Nicolas Mermod

Investment focus

Medical, Health Care, Life Science
Series A
Switzerland

Portfolio highlights

NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.

Patrick is a businessman active in real estate, wealth management, show business, hospitality, education and private equity, benefiting from a strong network. At Biowatch since November 2015.

Investment focus

Security, Wireless, Wearables
Seed
Switzerland

Portfolio highlights

Biowatch — I found a great domain name for sale on Dan.com. Check it out!

Reinhard Ambros

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
United States, Switzerland

Portfolio highlights

FORMA Therapeutics — Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Thorsten Schroeder

Investment focus

Electronics, Children, Life Science
Seed, Series B, Funding Round
United States, Brazil, Switzerland

Portfolio highlights

Storypod — The screen-free, educational audio toy that engages children independently & makes learning fun. Storypod delights toddlers, preschoolers, 1st, & 2nd graders with music, stories, songs, audiobooks, & podcasts. The Storypod audio player features recording from any phone, bedtime nightlight, sound machine, & white noise.
TROCAFONE — Trocafone is the first end-to-end e-commerce marketplace of LATAM that enable people to buy and sell used electronics hassle free, focused on smartphones in Brazil. At Trocafone they improve the selling and buying experience by acquiring the devices from sellers, refurbishing and re-selling them as pre-owned certified. Buyers enjoy the greatdeals of a peer-to-peer marketplace combined with the service, convenience, and safety of a retail store. Sellers enjoy a streamlined experience since It takes seconds to sell an item, and shipping is effortless with Trocafone's pre-addressed, pre-stamped mailers.
4D Lifetec — 4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics. It also offers a unique solution for DNA defect and repair based screening programs and is, therefore, the diagnostic method of the first choice. The company profits from different networks in science and healthcare.4D Lifetecprovides kits, reagents, download center, 4D life tanks, and service packages. They also offer cost savings for healthcare provider by its outstanding precision and a high degree of standardization both leading to a reduction of false positive results.4D Lifetec was founded by Dr. Arne Faisst and Nick Mijnssen in 2014 and is headquartered in Cham, Zug.

Arda Kara

Investment focus

Health Care, Medical, Software
Series A, Seed, Series B
United States, Germany, Switzerland

Portfolio highlights

Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)
Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.

Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).

Investment focus

Software, SaaS, Health Care
Seed, Series A, Series B
United States, Switzerland, United Kingdom

Portfolio highlights

Aiden — Reduce risk, enhance compliance, and simplify IT with modern, intelligent software packaging and deployment using Artificial Intelligence.
Compaas — Compaas: The Compensation Platform | Total Visibility. Zero Spreadsheets. Painless raise cycles, compensation metrics, people analytics, rewards letters
Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, United Kingdom

Portfolio highlights

Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
Cradle — Design better proteins

Tom Glocer joined BlueVoyant as Executive Chairman and Founder in 2017.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Series C
United States, United Kingdom, Israel

Portfolio highlights

GPTZero — Covered by >100 media outlets, GPTZero is the most advanced AI detector for ChatGPT, GPT-4, Bard. Check up to 50000 characters for AI plagiarism in seconds.
Cradle — Design better proteins
Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.

Tobias Reichmuth - Founding Partner at Maximon - The Longevity Company Builder @ Maximon

Investment focus

E-Commerce, Travel, Internet
Seed, Angel, Pre-Seed
Switzerland

Portfolio highlights

Firstcar — Firstcar provides car driving learning assistant services. They offer services that include hand-picked driving schools, student cars with double pedals for rent before and for the driving test, entry-level vehicles that are inexpensive to buy and maintain, support and advice on vehicle purchase, and selected insurances with special rates.
MyFeld.ch — MyFeld.ch is the holder of a fresh farm food platform that aims to create a digital link between consumers and our local agriculture. The company's platform provides products directly from the farm, allowing people to improve their comprehension of seasonality and regionality while also raising awareness of the sustainable use of food byallowing them to purchase fresh produce from the farm.
Testmate Health — Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home.

Lukas Speiser is the founder and CEO of Amorana.ch

Investment focus

Wellness, Nutrition, Health Care
Seed
Germany, Switzerland

Portfolio highlights

Dunatura — Dunatura engages in the manufacture and supply of vitamins and micronutrients.
Testmate Health — Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our firstsolution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home.

Feike has been the CEO and Chairman of the Managing Board of Directors of Royal DSM N.V. (a global Life Sciences and Materials Sciences company) since May 2007. In 1995, Feike became director of Gist-Brocades Food Specialties Division and joined Gist-Brocade’s executive committee. Following the acquisition by Royal DSM N.V. in 1998, he became adirector of the business group DSM Food Specialties. In 2000 he joined Royal DSM’s managing board of directors, becoming Chairman and CEO in May 2007.He is currently a member of the supervisory board of De Nederlandsche Bank (DNB, the Dutch Central Bank), and a board member of CEFIC (European Chemical Industry Council) and member of the Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC).His previous roles have included member of the Supervisory Board of DSM Netherlands, the Utrecht University, the Dutch Genomics Initiative (NGI) and the Anthonie van Leeuwenhoek Hospital/Netherlands Cancer Institute (NKI/AVL), chairman of Chemical Governors and a Global Agenda Council of the World Economic Forum, Dutch Food Chain Sustainability Foundation (DUVO) and of EuropaBio (European Biotech Association), a member of the Dutch Innovation Platform 2.0, board member of BIO (US Biotechnology Association), the Swiss Society of Chemical Industries (SCGI) and the Dutch Nutrition/Food Top-Institute (WCFS) and a member of the advisory board of ECP-EPN (e-commerce) and the Rotterdam Business School of the Erasmus University.

Investment focus

Biotechnology, Product Research
Seed
Switzerland

Portfolio highlights

Cradle — Design better proteins

As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases,and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.

Investment focus

Biotechnology, Health Care, Product Research
Seed
Switzerland, United States

Portfolio highlights

Cradle — Design better proteins
Kiwi Biosciences — Get enzymes specifically designed for FODMAP issues.

Igor Fish

Investment focus

Medical, Health Care, Life Science
Series A
Switzerland

Portfolio highlights

NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.

Lucian has a truly global outlook with an extensive set of contacts in North America, Europe, and Asia. Lucian is a venture capitalist and entrepreneur with several successful start-ups to his credit. He has 20 years of semiconductor industry experience. Lucian was born in Germany, educated in the French school system, and went on to earn a B.Sc.in International Economics from the School of Foreign Service at Georgetown University (with a minor in Russian) and an MBA from INSEAD.

Investment focus

Skiing, Sports, Fitness
Seed
Switzerland

Portfolio highlights

Adiposs — Adiposs is a Swiss biotech start-up company developing medical imaging products and technologies for early detection of cachexia.
Snowcookie — Ski tracking sensors by bode miller for racers and coaches

Tej Tadi is an Electronics Engineer and has pursued an advanced master in Virtual Reality & Computer Graphics at The Swiss Federal Institute of Technology (EPFL), Switzerland. During his PhD (EPFL), he set up an immersive virtual reality system in combination with state-of-the-art brain imaging technologies enabling trans-disciplinary work incognitive psychology, neuroimaging, and virtual reality. His research has led to important and highly visible scientific publications (Science) and awards (Pfizer Award for Neuroscience in 2009). Through his research, he has built a strong multi-disciplinary base spanning computer science, systems biology, neuroimaging, and computational and cognitive neuroscience. He founded MindMaze in 2011 to design and develop novel applications in Neuro-Rehabilitation, Game training & Interfaces. The technology platform from MindMaze will help in the neurology, psychiatry and sports rehabilitation.

Investment focus

Robotics, Neuroscience
Seed
Switzerland

Portfolio highlights

Metaphysiks — Metaphysiks is a groundbreaking immersive technology company combining world leading neuroscience and robotics to create multisensory experiences.

Beat Schillig - Founder @ Venture Kick

Investment focus

Information Technology, SaaS, Music
Seed, Series A
Switzerland

Portfolio highlights

TYXIT — TYXIT is linking musicians wirelessly without configuration, allowing a personal audio monitoring.
PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
1Drop Diagnostics — 1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.Their vision is to provide high quality medical information for everyone. They aim to increase accessto quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease.Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate